Daily Archives: November 13, 2021
Abemaciclib is approved by FDA with endocrine therapy for early breast cancer
November 13th, 2021 Breast CancerOctober 2021: The Food and Drug Administration has approved abemaciclib (Verzenio, Eli Lilly and Company) in combination with endocrine therapy (tamoxifen or an aromatase inhibitor) for adjuvant treatment of adult patients with hormone receptor .... Read More
Brexucabtagene autoleucel is approved by FDA for relapsed or refractory B-cell precursor acute lymphoblastic leukemia
November 13th, 2021 Blood cancer, LeukemiaOctober 2021: Brexucabtagene autoleucel (Tecartus, Kite Pharma, Inc.) has been approved by the Food and Drug Administration for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL).In ZUMA-3 (NCT0261406.... Read More